• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

SynGen

edit

SynGen Inc. enables regenerative cures through innovative engineering. The company invents and commercializes products that utilize single-use sterile plastic cartridge disposables mated to dedicated, highly automated electromechanical medical devices to isolate and capture stem and progenitor cells from peripheral and umbilical cord blood, bone marrow, and adipose tissue. Our products provide an important enabling platform for use in diagnostic, research, and clinical processes. Our inventions are based upon interdisciplinary fields that apply principles of engineering and life sciences to develop solutions required for regenerative medicine.

Recent Milestones

edit

• 
  SynGen received $5M in Series A funding. (4/18/12)
  Posted 4/18/12 at 9:01pm via bizjournals.com
• 
  SynGen added Philip H. Coelho as President and CEO.
  Posted 4/18/12 at 9:01pm

Videos

Screenshots

edit

Sources

1. SynGen Inc. Receives $5 million Equity Investment from Bay City Capital, LLC (bizjournals.com) [edit]